XML 110 R36.htm IDEA: XBRL DOCUMENT v3.20.1
Earnings Per Share (Tables)
3 Months Ended
Mar. 31, 2020
Earnings Per Share [Abstract]  
Schedule of computations of basic and diluted EPS
The presentation of basic EPS on the face of the accompanying condensed consolidated statements of operations is computed by dividing net income or loss by the weighted average shares of our common stock outstanding. The calculation of diluted EPS is similar to that for basic EPS, except that the denominator includes dilutive common stock equivalents and the numerator excludes the effects of dilutive common stock equivalents, if any. The computations of the numerator (income) and denominator (shares) to derive the basic and diluted EPS amounts presented on the face of the accompanying condensed consolidated statements of operations are as follows (in thousands):
 
 
 
 
 
 
 
 

 
Three Months Ended
March 31, 2020
 
Three Months Ended
March 31, 2019
 
Income
 
Shares
 
Income
 
Shares
Basic:
 
 
 
 
 
 
 
Net income (loss) attributable to common shareholders
$
(11,938
)
 
 
 
$
1,318

 
 
Less: Undistributed earnings allocated to participating securities

 
 
 
(12
)
 
 
Accretion of redeemable noncontrolling interests
(2,086
)
 
 
 

 
 
Net income (loss) available to common shareholders, basic
$
(14,024
)
 
148,863

 
$
1,306

 
147,421

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diluted:
 
 
 
 
 
 
 
Net income (loss) available to common shareholders, basic
$
(14,024
)
 
148,863

 
$
1,306

 
147,421

Effect of dilutive securities:
 
 
 
 
 
 
 
Share-based awards other than participating securities

 

 

 
330

Net income (loss) available to common shareholders, diluted
$
(14,024
)
 
148,863

 
$
1,306

 
147,751


Schedule of shares excluded from diluted EPS calculation
We had a net loss for the three-month period ended March 31, 2020. Accordingly, our diluted EPS calculation for this period excluded any assumed exercise or conversion of common stock equivalents. These common stock equivalents were excluded because they were deemed to be anti-dilutive, meaning their inclusion would have reduced the reported net loss per share in the applicable periods. Shares that otherwise would have been included in the diluted per share calculations assuming we had earnings are as follows (in thousands): 
 
Three Months Ended
 
March 31, 2020
 
 
Diluted shares (as reported)
148,863

Share-based awards
722

Total
149,585

 
In addition, the following potentially dilutive shares related to the 2022 Notes and the 2023 Notes were excluded from the diluted EPS calculation as they were anti-dilutive (in thousands):
 
Three Months Ended
March 31,
 
2020
 
2019
 
 
 
 
2022 Notes
8,997

 
8,997

2023 Notes
13,202

 
13,202